Novo Nordisk will sell its blockbuster weight-loss drug Wegovy for under half its normal price via a new direct-to-consumer online pharmacy.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Eli Lilly last week announced a $27 billion investment in four different domestic manufacturing plants to boost weight-loss drug production.
Now that semaglutide’s no longer in shortage territory, the FDA said drug-makers have 90 days to wrap up production of their Novo knockoffs.
It can be hard to sate investors’ appetites, but if there’s two companies who should know how to do it, it’s these two.
Pharma giant Merck on Tuesday announced in its earnings report that it would halt all shipments of HPV drug Gardasil to China.
Tech firms are seeking patents for AI-powered medical devices.
Americans make about 150 million trips to emergency departments each year. Their bank accounts wish they made far fewer.
Behind the blinding white light of Monday’s trillion–dollar AI wipeout that was a spot of unabashedly good AI news.
On Friday, the Danish pharma giant released the stellar results from a phase 1/2 trial for a once-weekly jab in its pipeline.
The pandemic saw a flurry of investment in biotech startups but the past three years have seen shrinking investments in the sector.
The US is the WHO’s biggest donor, chipping in roughly 18% of the organization’s $2 billion to $3 billion annual budget.
Some 8,000 industry movers and shakers are expected today for the annual JPMorgan Healthcare Conference, or simply JPM.
Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.
Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
One ring to rule them all… at least, Oura hopes so. On Thursday, it announced a new $200 million funding round.
By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals’ dominance in the GLP-1 space.